Fundraising Fox

Elegen

San Carlos, US · 8 known investors

elegenbio.com ↗

Elegant Bio develops DNA synthesis technology and services, offering ENFINIA™ DNA synthesis at scale for biotech and research applications.

BiotechDeep Techin /elegenbio@ElegenBio

Founders & leadership

MH
Matthew HillExecutive Officer, Director
PZ
Peter ZhouDirector
JS
Jonathan SheenaDirector
CM
Cain McClaryDirector

Investors · 8

ACVC PartnersSilicon Valley
Andreessen HorowitzMenlo Park · $500K – $50M
Raptor GroupMiami Beachvia Jim Pallotta · inferred
Triatomic CapitalPalo Alto · $100K – $1M
AME Cloud VenturesreportedPalo Alto · $1M – $10M
Digitalis VenturesreportedNew York · $100K – $10M
In-Q-TelreportedTysons · $100K – $2.5M
KdT Venturesreported · 2 sourcesAustin · $500K – $3M

Reported raises · per SEC filings

Form D private placements
▶$33MraisedMay 2024 · 28 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew HillExecutive Officer, Director
  • Peter ZhouDirector
  • Jonathan SheenaDirector
  • Cain McClaryDirector
Offering amount
$36M
Amount sold
$33M
First sale
May 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news